» Articles » PMID: 6178459

Effect of Sulphasalazine on Pulmonary Inactivation of Prostaglandin F2 Alpha in the Pig

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1982 Jun 1
PMID 6178459
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

1 The metabolism of prostaglandin F2 alpha (PGF2 alpha) 15 nm in 100,000 g supernatant fractions from piglet lung homogenates was inhibited by sulphasalazine with an IC50 value of 25 micrometers. 2 The piglet isolated lung perfused with Krebs solution, containing either albumin or Ficoll 70 to prevent oedema and vascular damage, efficiently metabolized PGF2 alpha given as a bolus injection (1 ng in 0.1 ml; 30 nm). 3 In Krebs solution containing Ficoll 70, sulphasalazine inhibited the pulmonary inactivation of PGF2 alpha in a dose-dependent manner with an IC50 value of 110 micrometers. No inhibition of inactivation by sulphasalazine was found when the perfusion fluid contained albumin, which is known to bind this drug effectively. 4 Analysis of the separated efflux profiles for PGF2 alpha and its metabolites with reference to the dilution curve for an extracellular marker provided evidence that sulphasalazine inhibited PGF2 alpha uptake into lung cells. 5 We conclude that the effect of sulphasalazine on pulmonary prostaglandin inactivation is primarily due to inhibition of prostaglandin transport, and not to inhibition of prostaglandin metabolism.

Citing Articles

The effect of sulfasalazine in pentylenetetrazole-induced seizures in rats.

Bora E, Karaali R, Akyol P, Yurtsever G, Erbas O Braz J Med Biol Res. 2021; 54(12):e11541.

PMID: 34878064 PMC: 8647899. DOI: 10.1590/1414-431X2021e11541.


Mechanism of action of 5-arninosalicylic acid.

Punchard N, Greenfield S, Thompson R Mediators Inflamm. 1992; 1(3):151-65.

PMID: 18475455 PMC: 2365334. DOI: 10.1155/S0962935192000243.


Proceedings of the British Pharmacological Society, University of Cambridge, 6th-8th April, 1983. Abstracts.

Br J Pharmacol. 1983; 79 Suppl:188P-425P.

PMID: 6652364 PMC: 2044764.


Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction.

Dawson C, Linehan J, Rickaby D, Roerig D Br J Pharmacol. 1984; 81(3):449-55.

PMID: 6538103 PMC: 1986855. DOI: 10.1111/j.1476-5381.1984.tb10097.x.


Purinoceptor mediated stimulation of prostacyclin release in the porcine pulmonary vasculature.

Hellewell P, Pearson J Br J Pharmacol. 1984; 83(2):457-62.

PMID: 6091831 PMC: 1987114. DOI: 10.1111/j.1476-5381.1984.tb16507.x.


References
1.
Anders N . Preparative thin-layer and column chromatography of prostaglandins. J Lipid Res. 1969; 10(3):316-9. View

2.
Alabaster V, Bakhle Y . Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970; 40(3):468-82. PMC: 1703190. View

3.
Raz A . Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A 2 , F 2 and E 2 to human plasma proteins. Biochem J. 1972; 130(2):631-6. PMC: 1174443. DOI: 10.1042/bj1300631. View

4.
Crutchley D, Piper P . Prostaglandin inactivation in guinea-pig lung and its inhibition. Br J Pharmacol. 1974; 52(2):197-203. PMC: 1776862. DOI: 10.1111/j.1476-5381.1974.tb09700.x. View

5.
Dawson C, Cozzini B, Lonigro A . Metabolism of [2-14C]prostaglandin E1 on passage through the pulmonary circulation. Can J Physiol Pharmacol. 1975; 53(4):610-5. DOI: 10.1139/y75-085. View